Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: Uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency-Reference-Cited by-同舟云学术

Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: Uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency

Published:2006-04-28 Issue:1-2 Volume:299 Page:23-35
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Tanaka Takao,Sohmiya Koichi,Kono Tatsuji,Terasaki Fumio,Horie Ryoichi,Ohkaru Yasuhiko,Muramatsu Michiko,Takai Shinji,Miyazaki Mizuo,Kitaura Yasushi

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11010-005-9032-3.pdf

Reference35 articles.

1. Aitman TJ, Gotoda T, Evans AL, Imrie H, Heath KE, Trembling PM, Truman H, Wallace CA, Rahman A, Dore C, Flint J, Kren V, Zidek V, Kurtz TW, Pravenec M, Scott J: Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet 16: 197–201, 1997

2. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76–83, 1999

3. Abumurad N, El-Maghrabi M, Amri E-Z, Lopez E, Grimaldi P: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 268: 17665–17668, 1993

4. Brinkmann JF, Abumrad NA, Ibrahimi A, Van Der Vusse GJ, Glatz JF: New insights in long-chain fatty acid uptake by heart muscle: crucial role for FAT/CD36. Biochem J 367: 561–570, 2002

5. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M: Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9: 294–299, 2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro inhibitor effect and molecular docking of thiamine (vitamin B ₁ ), riboflavin (vitamin B ₂ ), and reference inhibitor captopril on angiotensin-converting enzyme purified from sheep plasma;Archives of Physiology and Biochemistry;2024-07-10

2. Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Dietary Interventions;Hypertension;2023-07

3. The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology;Frontiers in Endocrinology;2022-10-24

4. U-Shaped Relation of Dietary Thiamine Intake and New-Onset Hypertension;Nutrients;2022-08-09

5. Therapeutic potential of vitamin B₁ derivative benfotiamine from diabetes to COVID-19;Future Medicinal Chemistry;2022-06